ESPERION THERAPEUTICS INC NE

CUSIP: 29664WAB1 Class: NOTE 4.000%11/1

Pentwater Capital Management LP's Holding History (CIK: 0001425851)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 10,861,000 Value ($000) $10,773 Avg Close — Range —
Q2 2025
Shares 10,861,000 Value ($000) $10,660 Avg Close — Range —
Q1 2025
Shares 10,861,000 Value ($000) $10,676 Avg Close — Range —
Q4 2024
Shares 10,861,000 Value ($000) $10,464 Avg Close — Range —
Q3 2024
Shares 10,861,000 Value ($000) $10,313 Avg Close — Range —
Q2 2024
Shares 10,861,000 Value ($000) $9,262 Avg Close — Range —
Q1 2024
Shares 26,861,000 Value ($000) $22,243 Avg Close — Range —
Q4 2023
Shares 34,111,000 Value ($000) $19,853 Avg Close — Range —
Q3 2023
Shares 46,411,000 Value ($000) $24,730 Avg Close — Range —
Q2 2023
Shares 46,411,000 Value ($000) $23,308 Avg Close — Range —
Q1 2023
Shares 46,411,000 Value ($000) $18,751 Avg Close — Range —
Q4 2022
Shares 46,411,000 Value ($000) $25,320 Avg Close — Range —
Q3 2022
Shares 46,411,000 Value ($000) $26,134 Avg Close — Range —
Q2 2022
Shares 46,411,000 Value ($000) $25,262 Avg Close — Range —
Q1 2022
Shares 46,411,000 Value ($000) $24,217 Avg Close — Range —
Q4 2021
Shares 46,411,000 Value ($000) $24,770 Avg Close — Range —